Recent clinical evidence supports a targeted therapeutic approach for genetic epileptic encephalopathies based on the molecular dysfunction.
Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy
Dilena, Robertino;STRIANO, PASQUALE;ZARA, FEDERICO;
2017-01-01
Abstract
Recent clinical evidence supports a targeted therapeutic approach for genetic epileptic encephalopathies based on the molecular dysfunction.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
